Oscar Health (OSCR) Current Deferred Revenue (2020 - 2026)

Oscar Health's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $172.0 million for Q1 2026.

• Quarterly Current Deferred Revenue rose 142.61% year-over-year to $172.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.0 million (up 142.61% YoY) and the FY2025 annual result came in at $166.2 million, up 123.42% from the prior year.
• Current Deferred Revenue was $172.0 million for Q1 2026 at Oscar Health, up from $166.2 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $172.0 million in Q1 2026 and bottomed at $60.0 million in Q2 2024.
• A 5-year average of $82.8 million and a median of $73.1 million in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue retreated 17.93% — and 2026, when it jumped 142.61%.
• Oscar Health's Current Deferred Revenue stood at $79.0 million in 2022, then declined by 16.56% to $65.9 million in 2023, then increased by 12.85% to $74.4 million in 2024, then jumped by 123.42% to $166.2 million in 2025, then advanced by 3.49% to $172.0 million in 2026.
• Business Quant data shows OSCR's Current Deferred Revenue at $172.0 million in Q1 2026, $166.2 million in Q4 2025, and $77.1 million in Q3 2025.